Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?

SIMPLE SUMMARY: Variant histologies of bladder cancer present at advanced stage and are often treated with radical cystectomy. As Nectin-4 appears to be a promising target for novel therapies in conventional bladder cancer, we aimed to analyze the expression of Nectin-4 and its prognostic value in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodler, Severin, Eismann, Lennert, Schlenker, Boris, Casuscelli, Jozefina, Brinkmann, Isabel, Sendelhofert, Andrea, Waidelich, Raphaela, Buchner, Alexander, Stief, Christian, Schulz, Gerald Bastian, Ledderose, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497069/
https://www.ncbi.nlm.nih.gov/pubmed/36139571
http://dx.doi.org/10.3390/cancers14184411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497069/
https://www.ncbi.nlm.nih.gov/pubmed/36139571
http://dx.doi.org/10.3390/cancers14184411

Ejemplares similares